Waldenström's Macroglobulinemia

This book sheds new light on clinical, biological and therapeutic data on the rare disease Waldenström's Macroglobulinemia (WM) with the participation of widely-recognized experts, involved in this field. It represents the efforts of physicians, scientists and patients, all around the world, to...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Leblond, Véronique. (Editor), Treon, Steve. (Editor), Dimoploulos, Meletios. (Editor)
Format: eBook
Language: English
Published: Cham : Springer International Publishing : Imprint: Springer, 2017.
Subjects:
ISBN: 9783319225845
Physical Description: IX, 377 p. 28 illus., 15 illus. in color. online resource.

Cover

Table of contents

LEADER 03064nam a22005655i 4500
001 101366
003 CZ-ZlUTB
005 20240914113352.0
006 m o d
007 cr nn 008mamaa
008 161006s2017 gw | fs |||| 0|eng d
999 |c 101366  |d 101366 
020 |a 9783319225845 
024 7 |a 10.1007/978-3-319-22584-5  |2 doi 
072 7 |a 616  |x Patologie. Klinická medicína  |2 Konspekt  |9 14 
080 |a 616.15  |2 MRF 
080 |a 616-097-092.19+577.27  |2 MRF 
080 |a 616.15-006.04  |2 MRF 
080 |a 616.428-006.44  |2 MRF 
080 |a (0.034.2:08)   |2 MRF 
080 |a (048.8:082)  |2 MRF 
245 1 0 |a Waldenström's Macroglobulinemia /  |c edited by Véronique Leblond, Steve Treon, Meletios Dimoploulos. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2017. 
300 |a IX, 377 p. 28 illus., 15 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a počítač  |b c  |2 rdamedia 
338 |a online zdroj  |b cr  |2 rdacarrier 
506 |a Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty 
520 |a This book sheds new light on clinical, biological and therapeutic data on the rare disease Waldenström's Macroglobulinemia (WM) with the participation of widely-recognized experts, involved in this field. It represents the efforts of physicians, scientists and patients, all around the world, to better understand and cure this rare disease. Considerable advances in the diagnosis, treatment indications, response criteria, prognostic factors and treatment options have been made since Dr Jan Waldenström first reported this "new syndrome" 70 years ago. Particularly instrumental in advancing of our understanding of WM have been the eight international workshops devoted to this disease. New, exciting molecular data have recently been reported, allowing us to revisit the oncogenic events leading to WM B-cell proliferation and to use newly available compounds targeting oncogenic pathways.- Resumé vydavatel 
650 0 7 |a hematologie  |7 ph114658  |2 czenas 
650 0 7 |a imunologie  |7 ph121051  |2 czenas 
650 0 7 |a maligní nemoci krve  |7 ph138681  |2 czenas 
650 0 7 |a non-Hodgkinův lymfom  |7 ph165202  |2 czenas 
650 0 9 |a hematology  |2 eczenas 
650 0 9 |a immunology  |2 eczenas 
650 0 9 |a blood cancer  |2 eczenas 
650 0 9 |a non-Hodgkin’s lymphomas  |2 eczenas 
655 7 |a elektronické knihy  |7 fd186907  |2 czenas 
655 7 |a kolektivní monografie  |7 ph165202  |2 czenas 
655 9 |a electronic books  |2 eczenas 
655 9 |a collective monographs  |2 eczenas 
700 1 |a Leblond, Véronique.  |e editor. 
700 1 |a Treon, Steve.  |e editor. 
700 1 |a Dimoploulos, Meletios.  |e editor. 
710 2 |a SpringerLink (Online service) 
776 0 8 |i Printed edition:  |z 9783319225838 
856 4 0 |u https://proxy.k.utb.cz/login?url=http://dx.doi.org/10.1007/978-3-319-22584-5  |y Plný text 
942 |2 udc 
992 |c NTK-SpringerMED 
993 |x NEPOSILAT  |y EIZ